US Department of Health and Human Services Announces Four New Senior Appointments for the Food and Drug Administration
The US Department of Health and Human Services has made four key leadership appointments to support reforms within the FDA and accelerate innovations in areas such as artificial intelligence.
The US Department of Health and Human Services announced four senior leadership appointments at the Food and Drug Administration to strengthen public health and modernize federal technologies.
First Appointment in Artificial Intelligence and Technology
Jared Seehafer has been appointed as the Food and Drug Administration's first Chief Technology and Artificial Intelligence Commissioner to lead the agency's work in technology and artificial intelligence.
Center for Drug Evaluation and Research
Michael Davis was selected as the director of the Center for Drug Evaluation and Research to manage the evaluation and research processes of drugs.
Center for Biologics Evaluation and Research
Karim Mikhail became the new director of the Center for Biologics Evaluation and Research, established to review the safety and efficacy of biological products.
Center for Tobacco Products Directorship
Bret Koplow was appointed to the directorship of the Center for Tobacco Products to carry out regulations and inspections regarding tobacco products.
Emphasis on Reform and Innovation
Ministry officials stated that these new appointments will accelerate the reforms needed to combat challenges in the health sector and support national health priorities.